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Abstract: 
MicroRNAs (miRs) are small, non-coding RNA molecules with important regulatory 
functions. It appears that miRs are involved in lymphocyte, specifically Natural Killer (NK) cell, 
homeostasis, activation, and over-activation leading to malignancy. The human NK cell is 
controlled by a milieu of activating and inhibitory signaling that explain its highly regulated role 
in the immune response. The role of miR-155 in NK cells is complex and has direct effects on a 
variety of signaling pathways. In terms of external control on miR-155, we note that miR-155 is 
synergistically induced in primary human NK cells after co-stimulation with IL-12 and IL-18 
cytokines. Additionally, miR-155 directly targets SHIP1, a molecule that is an important 
negative regulator of pathways involving survival and proliferation. Based on this preliminary 
data, we hypothesize that miR-155 plays a key role in regulation of activating pathways in 
NK cells. 
 In order to study the role of miR-155 in NK cells, a miR-155 transgene (tg) 
overexpression was driven via the lck promoter in C57BL/6 mice. Once again, MiR-155 targets 
and downregulates the inositol phosphatase SHIP1, which is a negative regulator of NK cell 
activation. Phenotypically, miR-155 tg mice have enlarged spleens with greater absolute number 
and percentage of NK cells. Using purified NK cells from spleens of miR-155 Tg and wild type 
(wt) mice, we observed that miR-155 upregulation increases NK cell cytotoxic activity against 
tumor cells utilizing both spontaneous cytotoxic and antibody dependent cell mediated cytotoxic 
pathways. NK cells from miR-155 tg mice have similar or lower levels of cytotoxic Perforin and 
Granzyme proteins compared to wt NK cells. Overexpression of miR-155 in primary mouse NK 
cells resulted in increased IFN-γ  secretion after stimulation with IL-12 and IL-18. These data 
link miR-155 expression with stimuli that strongly induce IFN-γ in NK cells and suggest that 
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miR-155 functions as a strong positive regulator of IFN-γ production. Mechanistically, we 
observed downmodulation of SHIP1 that correlates with an increase in PI3K and ERK, which 
are signaling regulators of NK cell cytotoxicity. Collectively our data indicate that NK cells 
overexpressing miR-155 exhibit enhanced cytotoxicity which is likely due to an increase in 
activating signaling. Overall, we have shown significant differences in activation and 
homeostasis suggesting that miR-155 can play a major role as a positive regulator of NK cell 
effector function. The study shows that miR-155 plays an important role in activation of NK cell 
immune function with implications for treatment of cancer. 
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Introduction: 
Chapter 1: The Natural Killer Cell 
The human immune response has traditionally been classified into two categories: innate or 
adaptive immunity.1 Innate immunity typically consists of cells originating from myeloid and 
lymphoid progenitors that function in a rapid, but non-specific manner. Adaptive immunity, on 
the other hand, consists of a specific, acquired response involving relatively long term memory 
that is carried out by two main players: T and B lymphocytes. Another major player in the 
human immune system, the natural killer (NK) cell is a large granular lymphocyte that is an 
important regulator of the body’s response to malignancies such as cancer and infection.2 NK 
cells are essential for the survival of the organism as evidenced by fatal infections resulting from 
NK-cell deficiencies in children.3 Physiologically, they are considered to be important as the 
body’s first line of defense against infection or malignant transformation and give the body time 
to mount a full scale adaptive immune response.4 For this system of classification, the human 
natural killer (NK) cell has characteristics of both innate and adaptive immunity.2,5 NK cells 
have deeply regulated functions with various levels of activation and inhibition mediated by 
receptor-ligand interactions and a large range of cytokines and chemokines.  
 
There are two theories that govern NK cell regulation: “missing self” and “induced self”6,7. The 
“missing self” theory postulates that NK cells are able to recognize and targets cells that have 
reduced or improper expression of “self” molecules that are normally expressed on healthy 
native tissue.8 These include major histocompatibility complex (MHC) and human leukocyte 
antigen (HLA) class 1 molecules. The “induced self” theory focuses on NK ligands that can be 
induced by cellular events such as stress6,9. In fact, there is evidence of both activating and 
6	  
inhibitory receptors, which suggests that NK cell function is controlled by a complex milieu of 
activation and inhibition. NK receptors that are associated with activation include cluster of 
differentiation 16 (CD16), NKG2D and NKp46 while receptors associated with inhibition 
include members of the killer cell immunoglobulin-like receptor (KIR) and Ly49 families of 
receptors. Additionally, there is evidence of overlap between MHC class 1 expression and 
receptors associated with “induced self”, which indicates that the two theories of NK regulation 
function cooperatively.6 The complexity of NK cell physiology is not only seen in their 
regulation but also in their mechanisms of immune action. 
 
Spontaneous Cytotoxicity and Associated Signaling: 
The classical notion that NK cells are members of the innate immune system is largely based on 
the NK cell’s ability to “spontaneously”, rapidly, and directly lyse potentially harmful target 
cells without specific acquisition of immune activation. This mechanism is typically associated 
with NK receptors such as NKG2D and NKp466. These receptors couple with a variety of 
tyrosine kinase based signaling events to result in NK cytotoxicity10. NKG2D, a well-studied 
natural cytotoxicity receptor, has been shown to noncovalently associate with DAP10 and 
additionally, in the case of mouse NK cells, immunoreceptor tyrosine-based activation motif 
(ITAM) bearing DAP12. Although DAP10 and DAP12 result in distinct signaling pathways, 
they often present redundancies in function based on some overlap in pathways, which 
characterizes a central theme to NK signaling11. In particular, activation of NK cell cytotoxicity 
can occur via both DAP10 and DAP12 dependent pathways, which ultimately converge on 
downstream activation of molecules such as Vav-1.12-14 Predominantly, NKG2D binding to 
target cell ligand results in downstream phosphoinositide 3-kinase (PI3K) activation. PI3K is a 
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catalytic heterodimer implicated in mechanistic regulation of cell survival, activation, and 
cytotoxicity. PI3K triggers a set of cellular events associated with Erk phosphorylation and 
downstream lytic granule mobilization.9,15,16 Of these lytic granules, Perforin first proceeds to 
permeabilize the target cell membrane to facilitate entry of lytic Granzyme proteins, which 
utilizes protease activity to facilitate target cell lysis.17 In this way, NK cells are able to recognize 
and directly destroy cells that present ligands indicative of stress or malignant transformation 
such as viral infection or cancer.  
 
Figure i: Summary of ITAM based signaling in NK cells. Note PI(3)K and downstream Akt and 
ERK targets that are essential for NK cell effector functions.9 
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Antibody Dependent Cell Mediated Cytotoxicity: 
The overall role of NK cells in the immune response goes far and beyond their “spontaneous” 
cytotoxic abilities. NK cells also express CD16, low-affinity Fcy receptor IIIA that binds to the 
Fc region of immunoglobulins such as IgG, which are usually bound to infectious agents, 
pathogens, or cancer cells. When CD16 forms an immunocomplex with IgG, it initiates a 
signaling cascade that ultimately results in NK cytotoxicity via molecules such as PI3K, Vav-1 
and ERK in a similar but distinct manner to the previously mentioned spontaneous cytotoxicity18. 
This immunoglobulin-dependent form of cytotoxicity is known as antibody dependent cell 
mediated cytotoxicity (ADCC). In fact, NK cell ADCC is utilized in many current treatments for 
cancer. Currently, there are many examples of targeted antibody therapies for cancer including 
trastuzumab for breast cancers, rituximab for B cell lymphomas, bevacizumab and cetuximab for 
metastatic colorectal cancers, and ofatumumab in chronic lymphocytic leukemia.19 
 
Cytokine Production: 
NK cells are potent secretors of proinflammatory and immunosuppressive cytokines including 
interferon (IFN)-γ, tumor necrosis factor (TNF)-a and interleukin (IL)-10. In fact, IFN-γ , the 
classical NK cytokine, has been shown to be essential for T cell response and colocalization of 
dendritic cells (DC).2 IFN-γ production is typically induced by a combination of monokines 
stimulatory signals and receptor-ligand activation.2 Various monokines such as IL-1, IL-2, IL-12, 
IL-15, and IL-18 have been shown to be important regulators of IFN-γ production. In fact, its 
release can be initiated within minutes of monokines stimulation.20 The release of IFN-γ by NK 
cells can in turn further activate the antigen presenting cells (APCs) such as monocytes, 
macrophages, and DCs to up-regulate MHC class I and increase APC cytokine secretion as 
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well.1,2 The production of these monokines by monocytes, macrophages, and DC confirms the 
complexity of interactions between various effectors of an immune response.  
 
Chapter 2: MicroRNA mediated regulation of NK cells 
In the last few years, there is a large body of research indicating the possible role of microRNA 
(miR) in regulating immune response, with dysregulation at the root of disease.2,21,22 First, RNA 
Polymerase II typically transcribes the primary transcript containing the miR sequence. This 
transcript is processed in the nucleus by the Drosha nuclease into a precursor miR and then 
exported into the cytoplasm. At this point, it is further processed by Dicer nuclease and then 
loaded into the RNA-induced silencing complex. This complex is able to target specific 3’ 
untranslated regions (UTRs) of messenger RNA (mRNA) and repress translation or induce 
mRNA degradation. 
MiR-155 and its target, SHIP1: 
In humans, miR-155 is transcribed from the B cell integration cluster MIR155HG gene. It has 
been shown to play a complex role in regulation of immunity with evidence of both positive and 
negative effects associated with its modulation. A rapid induction of miR-155 is observed in B 
and T lymphocytes following antigen receptor activation suggesting that it is important for 
induction of immune response.3,21 Further, it is required for the normal immune function of B, T, 
and dendritic cells as evidenced by severe immune deficiency upon its loss.4,23 On the other 
hand, it is clear that the homeostatic balance of cellular miR-155 is crucial to proper function and 
signaling based on evidence that overexpression of miR-155 is linked to cases of B cell 
lymphoma, myeloid lymphoma, and myeloproliferative disorder in mice.2,5,24,25 In mice given 
allogeneic hematopoietic stem cell transplants, miR-155 regulates the severity of consequent 
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acute graft versus host disease. This, along with other studies, suggests a proinflammatory role 
for miR-155.6,7,26-29  
 
Recently there have been studies regarding the role of miR-155 in immune cells and particularly 
NK cells. In NK cells, miR-155 represses mRNA translation and/or induces mRNA degradation 
with one particular important regulatory molecule, SH2 domain containing inositol 5-
phosphatase I (SHIP1).8,30 SHIP1 is a negative regulator of activation and survival. While PI3K 
has been shown to convert the membrane phosphatidylinositol-(4,5)-bisphosphate (PI4,5P2) to 
phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) in order to initiate signaling associated with 
cell survival and activation, SHIP1 does the reverse and converts PI4,5P2 to PIP3 making it a 
negative regulator of NK cell activity.6,9,31,32 Specifically in human NK cells, miR-155 is the 
most highly induced miR following costimulation with monokines, IL-12 and IL-186,30. 
Interestingly, miR-155 is the only known microRNA that targets the 3’UTR region of SHIP1 
mRNA.  
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Figure ii: Pathway of microRNA processing 33 
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pri-miRNA cleavage by the Drosha–DGCR8 microprocessor complex. 
The pri-miRNA is next endonucleolytically cleaved by the nuclear micro-
processor complex formed by the RNase III enzyme Drosha (RNASEN) 
and the DGCR8 (DiGeorge critical region 8) protein (also known as Pasha 
(Partner of Drosha) in D. melanogaster and C. elegans)36 (Fig. 2a). DGCR8/
Pasha contains two double-stranded RNA-binding domains and is essen-
tial for miRNA processing in all organisms tested37–40. An average human 
pri-miRNA contains a hairpin stem of 33 base-pairs, a terminal loop and 
two single-stranded flanking regions upstream and downstream of the 
hairpin. The double-stranded stem and the unpaired flanking regions 
are critical for DGCR8 binding and Drosha cleavage, but the loop region 
or the specific sequences are less important for this step41–43. A single 
nucleotide polymorphism in a miRNA precursor stem can block Drosha 
processing44. Nevertheless, many miRNA sequence aberrations observed 
in human tumours alter the secondary structure without affecting process-
ing, and reveal the structural flexibility of the microprocessor34.
The two RNase domains of Drosha cleave the 5´ and 3´ arms of the pri-
miRNA hairpin39, whereas DGCR8 directly and stably interacts with the 
pri-miRNA and functions as a molecular ruler to determine the precise 
cleavage site41. Drosha cleaves 11 base pairs away from the single-stranded 
RNA/double-stranded RNA junction at the base of the hairpin stem.
Drosha-mediated cleavage of the pri-miRNA occurs co-transcriptionally 
and precedes splicing of the protein-encoding or non-coding host RNA 
that contains the miRNAs. Splicing is not inhibited by Drosha-mediated 
cleavage, because a continuous intron is not required for splicing45,46.
microRNA-specific regulation of the microprocessor complex. 
Drosha-mediated pri-miRNA processing was recently shown to be 
subject to regulation by miRNA-specific mechanisms. Drosha forms 
two different complexes, a small microprocessor complex that contains 
only Drosha and DGCR8 and processes many pri-miRNAs, and a larger 
complex that contains RNA helicases, double-stranded RNA binding 
proteins, heterogeneous nuclear ribonucleoproteins and Ewing’s sarcoma 
proteins38. The RNA helicases p72 and p68 are part of the large Drosha 
complex and might act as specificity factors for the processing of a sub-
set of pri-miRNAs (Fig. 2b). Expression levels of several miRNAs are 
reduced in homozygous p68−/− or p72−/− knockout mice, whereas other 
miRNAs remain unaffected47.
Drosha-mediated cleavage can also be regulated for individual miR-
NAs: the heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) 
binds specifically to pri-miR-18a and facilitates its processing. Loss of 
hnRNP A1 diminishes the abundance of mature miR-18a (Fig. 2c), but 
hnRNP A1 does not have any impact on other miRNAs that are located 
in the same miR-17 genomic cluster, demonstrating the extraordinary 
specificity of miR-18a biogenesis48. hnRNP A1 binds to the conserved 
loop of the pri-miR-18a and changes the hairpin conformation to create 
a more favourable cleavage site for Drosha49. About 14% of the human 
pri-miRNA loops are conserved between different species and could 
provide anchor points for similar regulatory mechanisms.
Transforming growth factor-β (TGF-β) and bone morphogenetic 
factors (BMPs) induce the maturation of miR-21 by regulating the 
microprocessor activity. TGF-β and BMP bring about the recruitment 
3´
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Figure 1 The ‘linear’ canonical pathway of microRNA processing. The miRNA 
processing pathway has long been viewed as linear and universal to all 
mammalian miRNAs. This canonical maturation includes the production of 
the primary miRNA transcript (pri-miRNA) by RNA polymerase II or III and 
cleavage of the pri-miRNA by the microprocessor complex Drosha–DGCR8 
(Pasha) in the nucleus. The resulting precursor hairpin, the pre-miRNA, is 
exported from the nucleus by Exportin-5–Ran-GTP. In the cytoplasm, the 
RNase Dicer in complex with the double-stranded RNA-binding protein TRBP 
cleaves the pre-miRNA hairpin to its mature length. The functional strand of 
the mature miRNA is loaded together with Argonaute (Ago2) proteins into the 
RNA-induced silencing complex (RISC), where it guides RISC to silence target 
mRNAs through mRNA cleavage, translational repression or deadenylation, 
whereas the passenger strand (black) is degraded. In this review we discuss 
the many branches, crossroads and detours in miRNA processing that lead to 
the conclusion that many different ways exist to generate a mature miRNA.
Editing is defined as a post-transcriptional change of RNA sequences 
by deamination of adenosine (A) to inosine (I), altering the base-
pairing and structural properties of the transcript. Editing of miRNA 
transcripts by ADAR1 and ADAR2 was first described for miR-22 
(ref. 116) followed by miR-151, miR-197, miR-223, miR-376a, miR-
379 and miR-99a (ref. 117), as well as miR-142, miR-223, miR-1-1 
and miR-143 (ref. 118). In pri-miR-142, A-to-I editing inhibits its 
cleavage by the endonuclease Drosha and results in its degradation 
by the ribonuclease Tudor-SN, which preferentially cleaves double-
stranded RNA containing inosine–uracil pairs118,119. However, edit-
ing of other pri-miRNAs was shown to enhance their processing by 
Drosha120. Editing can also influence further downstream processing 
steps: pri-miR-151 editing abolishes its cleavage by Dicer in the cyto-
plasm. It remains to be established whether miRNA editing events 
are predominantly nuclear or cytoplasmic and whether they occur 
on the pri-miRNA or on the precursor miRNA (pre-miRNA)121. In 
addition to altering miRNA processing, miRNA editing can have 
an impact on miRNA target specificity. For example, a single A-to-I 
change in the miR-376 precursor redirects the mature miRNA to 
a new target, resulting in altered protein expression in mice122. In 
summary, miRNA editing can influence processing at multiple steps 
or can change the miRNA complementarity to target sequences, 
increasing the diversity of the cellular miRNA pool.
BOX 1 microRNA editing
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Chapter 3: Approach 
To recap, evidence suggests the miR-155 is essential for the human immune response and is 
associated with immune activation. Additionally, SHIP1, a known negative regulator of NK cell 
activation and cytotoxicity, is a primary target of miR-155. Thus, we hypothesized that miR-155 
can act as a positive regulator of NK cell activity and cytotoxicity. In order to test this 
hypothesis, we utilized a mouse model overexpressing a miR-155 transgene off of the 
lymphocyte specific protein kinase (lck) promoter, which allows expression in specifically NK 
cell and T lymphocytes.  
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Materials and Methods: 
Mice: 
The lck-miR-155 C57BL/6 (B6) tg mouse was used from a single founder as previously 
described.6,26 Littermates 8.5-14 weeks were used for experiments. Animal work was approved 
by The Ohio State University Animal Care and Use Committee. 
 
NK cell preparations: 
All experiments were performed with purified primary mouse NK cells from splenic homogenate 
via microbead selection columns (Miltenyi Biotech Inc.) followed by FACS for NK1.1+ CD3ε- 
cell subset giving >99.5% purity using abs (clones) from BD Biosciences reactive against: 
NK1.1 (PK136) and CD3ε (145-2C11). Isolated mouse NK cells were cultured in RPMI-1640 
(Invitrogen) containing 900 IU/ml of human IL-2 (Hoffman-LaRoche Inc.) and 55µM β-
mercapethanol (Gibco) at 37 C. Splenic NK cell percentages and absolute numbers were 
determined by flow cytometric analysis of total splenic cell isolate for NK1.1+ CD3ε- NK cells. 
Analysis was performed with FlowJo v7.6.1 (TreeStar). 
 
Cell lines:  
The YAC-1 murine T-lymphoma cell line was maintained in RPMI-1640 (Invitrogen), and the 
murine mastocytoma P815 cells were maintained in DMEM medium (Invitrogen), both with 
10% Fetal Bovine Serum (FBS) (Invitrogen) and 2 mM L-glutamine (Gibco). 
 
Cell stimulation.  
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Wt and miR-155 tg NK cells were stimulated with human IL-2 (90 ng/ml) or IL-12 (20 ng/ml; 
Genetics Institute Inc.) plus IL-18 (10 ng/ml; R&D Systems) for indicated times. For stimulation 
with YAC-1 tumor cells, NK cells were expanded in IL-2 for eight days, starved from IL-2 for 2 
hours on ice to bring cells back to resting conditions, and mixed YAC-1 cells fixed with 1% 
paraformaldehyde at a 5:1 effector:target ratio and stimulated for the indicated times. 
 
NK cell IFN-γ production:  
Sorted subsets from wt and miR-155 tg NK1.1+CD3- NK cells were untreated or stimulated with 
indicated monokines Results are shown as the means of triplicate wells ± SEM.34  
 
Cytotoxicity assays: 
YAC-1 or P815 cells coated with an anti-mouse lymphocyte rabbit Ab (Accurate Chemical) 
were used as targets in a 4-hour 51Cr release assay10,35 with fresh NK cells or NK cells cultured in 
IL-2 90 ng/ml for 8 days. 
Conjugate formation:  
Immune complex formation among NK cells and YAC-1 tumor cells were examined by flow 
cytometry. YAC-1 tumor cells were infected using the GFP encoding lentivirus vector pCDH 
(System Biosciences) and sorted for GFP+ cells. For the conjugate assay, 2x105 PE-labeled 
NK1.1+CD3- NK cells were mixed with 2x105 GFP+ YAC-1 cells in 200 µl of cold RPMI-1640 
with 10% FBS and centrifuged at 600 rpm for 1 min. To induce the formation of immune-
complexes, cells were incubated at 37 C for 0 and 10 min. Reactions were stopped with ice cold 
PBS. NK1.1+ GFP+ conjugates were detected by FACS analysis.11,36 
 
15	  
Western blot analysis: 
NK cells were harvested and lysed into RIPA buffer or directly lysed in Laemmli buffer (2x105 
cells/20 µl) as described22. Western blots were performed according to published protocols and 
Ab-reactive proteins were detected as described20. Abs used: the anti-SHIP1, anti-actin, and 
anti-Granzyme M (Santa Cruz Biotechnology); anti-Granzyme B, anti-perforin, anti-phospho-
AKTSer473, and anti-phospho-ERKThr202/Tyr204 (Cell Signaling Technology). 
 
Real-time RT-PCR: 
RNA was extracted using Trizol (Invitrogen). Reverse transcription was performed with Taqman 
MicroRNA Reverse Transcription Kit and RT primers specific for miR-155 and U6 or 292 as 
control (Applied Biosystems). Real-time RT-PCR reactions were performed as described15. 
Data were analyzed with the comparative CT method using internal control U6 or 292 RNA 
levels to normalize differences in sample loading. Results (mean ± SEM of triplicate reaction 
wells) represent the n-fold difference of transcript levels in a particular sample compared to 
samples of wt NK cells. 
 
Statistics:  
Data were compared using Student’s 2-tailed t-test. A p value < 0.05 was significant. Survival 
data were analyzed using Kaplan-Meier and long-rank test methods (GraphPad Prism Version 
5.0). 
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Results: 
Effect of miR-155 overexpression on NK cell number 
To investigate the effects of miR-155 overexpression in NK cells, we used lck-miR-155 
transgenic (tg) mice, which were previously generated.12-14,26 We quantified miR-155 expression 
from RNA using RT-Realtime PCR obtained from NK1.1+ CD3- fluorescence activated cell 
sorting (FACS) for wt and miR-155 tg NK cells. We confirmed significantly higher values of 
miR-155 in the miR-155 tg NK cells compared to the wt NK cells (average induction of 26.6 +/- 
5.3 fold; Figure 1A; p<0.0001, n=6). MiR-155 tg mice also had a higher percentage of splenic 
NK1.1+ CD3- NK cells compared to wt mice (Figure 1B, p<0.0001; n=16), and a higher 
absolute number of NK cells (Figure 1C; p<0.0001; n=13).  
 
MiR-155 overexpression enhances NK cell cytolytic function: 
We compared the ability of FACS sorted NK1.1+ CD3- NK cells from miR-155 tg and wildtype 
(wt) mice to kill the YAC-1 T cell lymphoma cell line and the RMA cell line expressing NKG2D 
ligand, Rae1B. Freshly isolated miR-155 tg NK cells lysed YAC-1 lymphoma targets (p<0.01, 
n=9) and RMA-Rae1B (p<0.02, n=5) with significantly higher efficiency compared to wt NK 
cells (Figure 2A). Additionally, miR-155 tg NK cells had significantly higher ADCC response 
against anti-lymphocyte antibody coated P815 mastocytoma cell line targets when compared to 
wt NK cells incubated with IL-2 for eight days (Figure 2B; p<0.001, n=5). To investigate 
potential cellular mechanisms responsible for the significantly enhanced NK cell cytolysis in 
miR-155 tg NK cells, we first analyzed protein levels of Granzyme B, Granzyme M and perforin 
by Western blot analysis. Interestingly, Granzyme B protein levels were significantly decreased 
in freshly isolated resting miR-155 tg NK cells compared to wt NK cells yet this downregulation 
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disappeared following activation in the presence of IL-2 for eight days (Figure 3C). It is worth 
noting that Granzyme B is not a known target of miR-155. No significant differences were 
otherwise observed in levels of Granzyme M and perforin in miR-155 tg vs wt NK cells. 
Effector-target conjugate formation is critical for NK cell cytotoxicity. As shown in Figure 3D, 
miR-155 tg NK cells have a significantly enhanced ability to form conjugates with YAC-1 cells 
when compared to wt NK cells (Figure 3D; p<0.01, n=3). This provides mechanistic evidence to 
partially explain the enhanced ability of miR-155 NK cells to kill tumor cell targets compared to 
wt NK cells. 
 
MiR-155 in the regulation of IFN-γ production by IL-12 and IL-18 costimulated NK cells: 
Indeed, miR-155 tg NK cells secreted greater amounts of IFN-γ when compared to wt NK cells 
following in vitro stimulation with IL-12 plus IL-18 monokines (Figure 4; p<0.001; n=6) 
 
Effect of miR-155 on SHIP1 expression and PI3K associated signaling: 
SHIP1 is downregulated in miR-155 tg mouse NK cells (Figure 5A). As discussed in Chapter 2 
of the Introduction, SHIP1 is a negative regulator of the PI3K. AKT is a downstream target of 
PI3K and provides a method of measuring PI3K activity.9,15,16 Following activation by either IL-
2 or IL-15 (and occasionally in medium alone), AKT was visibly more activated by 
phosphorylation in miR-155 tg NK cells compared to wt NK cells (Figure 5B). ERK is also a 
downstream target of PI3K in NK cells and is associated with NK cell lytic function.15,17 We 
found that its activation by phosphorylation was visibly higher in miR-155 tg NK cells compared 
to wt NK cells cultured in IL-2 or IL-15, and occasionally at rest in medium alone (Figure 5B). 
Since ERK signaling regulates cytotoxicity in NK cells we also quantified ERK phosphorylation 
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after binding YAC-1 tumor target cells. MiR-155 tg NK cells have higher levels of active, 
phosphorylated ERK compared to wt NK cells after conjugation with YAC-1 tumor target cells 
(Figure 5C). When stimulated with monokines or tumor target binding, miR-155 tg NK cells 
show enhanced activation of AKT and ERK when compared to wt NK cells. 
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Discussion: 
NK cells are amongst the first immune cells to respond to a site of viral infection or malignant 
transformation. This rapid response, in conjunction with the NK cell’s ability to recognize 
malignancies via MHC class 1 mismatch or induced NK receptor activation, give the NK cell a 
key role in immune surveillance against cancer. For these reasons, enhancement of NK cell 
activity presents a viable option for effective cancer therapies.  
MicroRNA regulation is on the forefront of modulation of gene expression and control of 
intracellular signaling mechanisms. In this report, we investigated the role of miR-155 on the 
homeostasis and function of NK cells in an lck-miR-155 tg mouse model. Increased splenic 
percentage of NK cells and an overall increase in absolute number of splenic NK cells suggest 
evidence of a cellular homeostatic change. Presumably this is occurring due to miR-155 
repression of SHIP1, a known negative regulator of cell survival, proliferation, and 
activation.18,37 Although we later present data suggesting increased levels of NK cell 
cytotoxicity, this increase in NK cell number and percentage already presents an advantage to 
immune surveillance of cancer.   
 The observed increase in NK cell cytolytic activity against both YAC-1 and RMA-Rae1B 
T cell lymphoma lines can be due to various changes in NK cell phenotype and activation. 
Theoretically, miR-155 could be modulating expression of activating or inhibitory receptors on 
the NK cell surface or could be granting the NK cells a general heightened state of activation and 
metabolism. The evidence presented in this report suggests that miR-155 overexpression results 
in a heightened state of activation mediated through ERK signaling. Mechanistically, ERK has 
been associated with mobilization of lytic granules in the direction of the target cell to result in 
efficient lysis.15,19 This brings up the issue of granule expression in the miR-155 tg NK cells 
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compared to those of the wt. Prior to activation during resting conditions, miR-155 tg NK cells 
express lower levels of Granzyme B protein compared to wt NK cells. The enhanced killing by 
freshly harvested miR-155 NK cells must not be affected by Granzyme B protein expression, 
which begs to question, what is causing the increased levels of cytotoxicity? It is seen that NK 
cells from Granzyme B-/- mice still express some cytotoxicity2,38, suggesting that it is not solely 
essential for response. It is possible that other Granzymes are compensating for the loss of 
Granzyme B or that a rapid translational induction occurs after target cell binding. It is likely that 
miR-155 plays a large role in events leading up to lysis such as granule mobilization, 
cytoskeleton reorganization, and our data concerning increased levels of target cell conjugation 
with miR-155 tg NK cells. It is worth noting that the low expression of Granzyme B is most 
likely not due to direct repression and binding by miR-155 as the 3’UTR of Granzyme B mRNA 
does not have sufficient complementarity to allow for miR-155 binding. It has been shown that 
miR-223 directly binds to the 3’UTR of Granzyme B mRNA and miR-223 expression is 
downregulated by IL-15 activation.2,39 The role that miR-155 plays in modulating NK cell 
homeostasis maybe be linked through the IL-15 receptor pathways, thus modulating miR-223 
expression and Granzyme B protein levels. The interaction between Granzyme B and miR-155 
needs further investigation.  
 The observation that miR-155 causes enhancement of not only spontaneous cytotoxicity, 
but also IFN-γ secretion and ADCC, suggests that its role in NK cell activation is broad and 
powerful. This is not surprising considering that miR-155 expression has been shown to be 
essential for normal immune function of B, T and dendritic cells.20,23 Although these immune 
cells play different roles in regulating response to malignancy and pathogenic infection, there is 
some conservation of signaling which may be associated with the role of miR-155. Looking 
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specifically at NK cells, miR-155 negatively regulates SHIP1 and activates PI3K signaling, a 
known modulator of many NK cellular events associated with activation.15 This activation can 
explain enhanced ADCC40, increased IFN-γ  secretion31, as well as homeostatic modulation41. 
Looking specifically at IFN-γ secretion, our lab has specifically studied the role of SHIP1 in this 
key pathway. Utilizing NK92 human cell lines, we have observed that overexpression of SHIP1 
via a Pinco vector decreases NK92 IFN-γ secretion compared to vector alone. This confirms our 
hypothesized roles of miR-155 and SHIP1 and confirms that an interaction between the two may 
be indeed the reason for our observed effects.  
When comparing effects seen between spontaneous cytotoxicity and ADCC, we observe 
that different levels of activation are needed for both responses. This suggests that both 
processes, although similar in cytolytic effect, operate under unique methods of control. For 
spontaneous cytotoxicity, the rapid response and high levels of cytolytic activity witnessed in 
freshly isolated and resting miR-155 tg NK cells compared to wt aligns with the innate response 
of the NK cell and is the hallmark of its role in the first line of defense. It also suggests that miR-
155, in this case, is playing a role in mediating the innate, direct, nonspecific response of the NK 
cell. However under activation with IL-2 for eight days, the differences between miR-155 tg NK 
cells and wt NK cells disappear. This is most likely due to long periods of activation at which 
point the NK cells may reach a maximum level of activity. Notably, high levels of activation do 
occur in the human body after the innate response has already started in the form of intercellular 
signaling via monokines and cytokines. Even in these instances of high activation where 
spontaneous cytotoxicity reaches a maximum, miR-155 manages to still modulate NK response 
via ADCC cytolytic pathways that more resemble adaptive immune pathways. Characteristic of 
adaptive pathways, NK ADCC is extremely low and difficult to detect at resting, freshly isolated 
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conditions. Still, we have observed higher levels of ADCC in the miR-155 tg mice compared to 
the wt. On the other hand, when the NK cell reaches a state of heightened activation via 
monokine stimulation, ADCC becomes more active, plays a larger role in cytolytic activity and 
is still higher in miR-155 tg NK cells compared to wt. Looking at how miR-155 is able to 
regulate both innate pathways that require low activation, and adaptive immune response that 
requires time and antibody presentation shows not only the versatility of the NK cell, but also the 
broad reach of microRNA regulation as witnessed with miR-155. 
In addition to this, the full role of miR-155 in NK cells is still not well characterized. 
Many microRNA have hundreds of mRNA targets with complex cellular roles42. In T 
lymphocytes, miR-155 targets Suppressor of Cytokine Signalling 1 (SOCS1), which plays an 
important role in differentiation and activations43. If a similar event is occurring in NK cells, the 
downstream signaling would indeed be much more complex than simple PI3K activation.  
In summary, we show the overexpression of miR-155 in NK cells positively regulates 
NK lytic function while modulating homeostatic balance. The elucidation of factors that control 
these processes is important for host defense. The selective enhancement of miR-155 in NK cells 
via direct delivery of miR-155 oligonucleotides via nanoparticle mediated control44 could 
improve NK cell activation against progressive cancers or infections while avoiding the well-
known toxicities that patients have encountered when undergoing systemic administration of NK 
cell-activating cytokines such as IL-2 or IL-12. Additionally, this could improve already existing 
antibody therapeutic for specific cancers that function via NK ADCC19. 
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Figure legends: 
Figure 1. NK cell expansion in miR-155 tg mice. (A) NK1.1+CD3- FACS sorted NK cells from 
spleen of wt and miR-155 tg mice were analyzed for miR-155 expression by Real-time RT-PCR. 
The graph is representative of 6 experiments with similar results. Results are expressed as the 
mean ± standard error mean (SEM) of triplicate wells. (B) Freshly isolated splenocytes of wt and 
miR-155 tg were stained with anti-NK1.1 and anti-CD3e Abs and analyzed by flow cytometry 
for percentage of NK1.1+CD3- cells. (C) The absolute number of NK cells was calculated in 
spleens of wt versus miR-155 tg mice. The graph summarizes data from 4 wt and 2 miR-155 tg 
littermate mice.  * Statistically significant; see text for details. 
Figure 2. Effect of miR-155 overexpression on NK cell cytotoxic effector functions.  
A) FACS sorted NK1.1+CD3- NK cells from wt and miR-155 tg mice were used as effector cells 
in a 4-hour 51Cr release assay using YAC-1 and RMA-Rae1b lymphoma target cells. E:T 
correlates with percent target cell lysis.  B) Eight days after expansion in IL-2, sorted wt and 
miR-155 tg NK cells were tested for ADCC against 51Cr labeled P815 mastocytoma IgG Ab 
coated targets cells. * Statistically significant; see text for details. 
Figure 3. Effect of miR-155 overexpression on cytotoxicity associated NK functions 
 C) Resting (left) and IL-2 activated (8 days; right) NK1.1+CD3- wt and miR-155 tg NK cells 
were analyzed for Granzyme B, Granzyme M and perforin protein levels by Western blot using 
actin as a loading control.  D) Left: wt and miR-155 tg NK cells labeled with PE-conjugated anti-
NK1.1 Ab were incubated with GFP+ YAC-1 tumor cells. Conjugate formation was analyzed 0 
minutes and 10 minutes after incubation using flow cytometry. NK cell-target cell conjugates 
were gated and identified as NK1.1+GFP+ events.  The percentages of conjugates are shown on 
top of the representative dot plots.  Right: The graph summarizes the data of conjugate formation 
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obtained from three wt and three miR-155 tg NK cell samples co-incubated with YAC-1 tumor 
cells. * Statistically significant; see text for details. 
Figure 4. The effect of miR-155 overexpression on NK cell IFN-γ  production   
Wt and miR-155 tg NK1.1+CD3- NK cells were each co-stimulated in vitro for 18 hours at 37 C 
using IL-12 (20 ng/ml) and IL-18 (10 ng/ml) and supernatants were analyzed for IFN-g secretion 
by ELISA. * Statistically significant; see text for details. 
Figure 5. Effect of miR-155 overexpression on SHIP1 protein expression and AKT and ERK 
activation in NK cells.  A) NK1.1+CD3- NK cells from wt and miR-155 tg mice were analyzed for 
SHIP1 protein levels by Western blot.  Actin was assessed to ensure equal loading.  B) 
NK1.1+CD3- NK cells from wt and miR-155 tg mice were left untreated or stimulated with IL-2 
(90 ng/ml) or IL-15 (100 ng/ml) for 10 minutes. Western blot analysis was performed on total 
lysates using anti-phospho-ERKThr202/Tyr204, anti-phospho-AKTSer473 and actin Abs. C) NK1.1+CD3- 
NK cells from wt and miR-155 tg mice and paraformaldehyde-treated YAC-1 cells were mixed 
and incubated at ratio 5:1 for the indicated times. Lysates from NK and YAC-1 samples were 
analyzed by Western blot using anti-phospho-ERKThr202/Tyr204 and actin Abs.  These blots are 
representative of at least two independent experiments. * Statistically significant; see text for 
details. 
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